Ethnopharmacological Relevance:
The traditional Chinese medicine formula Danggui-Shaoyao-San (DSS) has been reported to show therapeutic effect on alleviating the symptoms of Alzheimer's disease (AD).
Aim Of The Study:
The present study aims to investigate the relation between DSS treatment of AD and DHA metabolism and evaluates its neuroprotective effect on cognitive in APP/PS1 mice.
Material And Methods:
DSS (1.6, 3.2, 6.4 g/kg/day) or Aricept (3 mg/kg/day) was orally administered (i.g.) to APP/PS1 mice, and saline was orally administered to Wild-type (WT) male mice as control group. Then, the Morris water maze (MWM) test, Y-maze spontaneous alternation test, open filed test and fear conditioning test were conducted for evaluation of learning and memory abilities. The DHA content was assessed by HPLC-MS/MS. Physiological indices were determined, including triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), ROS level, activity of superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA), PEG2, TXB2 and LTB4. The expressions of COX-1, COX-2, cPLA2, iPLA2, 15-LOX, and were assessed by Western blot.
Results:
APP/PS1 mice showed serious cognitive impairment in behavioral tests. However, treatment of DSS extract significantly ameliorated the cognitive deficits of APP/PS1 mice. Biochemical measurements showed the increases in TG, TC, LDL-c and the decrease in HDL-c in APP/PS1 mice compared with WT mice, and DSS extract significantly retarded these changes. Low content of DHA, low expression of iPLA2 and 15-LOX were observed both in hippocampus and cortex of APP/PS1 mice, while DSS extract significantly restored these changes. Additionally, the abnormal activity of SOD and ROS level, the decreased levels of MDA and GSH were observed in APP/PS1 mice, while DSS extract prominently lessened these changes. Moreover, DSS extract decreased the level of PEG2, TXB2 and LTB4 and also attenuated the expression of cPLA2, COX-1 and COX-2 in hippocampus as well as cortex of APP/PS1 mice.
Conclusions:
Based on these results, we suggest that DSS play a positive effective role in increasing DHA content by up-regulating iPLA2 and 15-LOX, resulting in ameliorating oxidative stress and inflammation and finally ameliorating cognition deficits in APP/PS1 mice.
Citing Articles
Exploring the therapeutic potential of Danggui Shaoyao San in nephrotic syndrome: Impact on skin sodium content and renal function.
Xiang Q, Ni L, Xu Z, Ma X, Wang Y, Xuan Z
Heliyon. 2025; 11(4):e42577.
PMID: 40051859
PMC: 11883388.
DOI: 10.1016/j.heliyon.2025.e42577.
UHPLC-Q Exactive-Orbitrap-MS and network pharmacology analyses to investigate the mechanism by which Danggui-Shaoyao-San affects 27-OHC-induced cell damage in SH-SY5Y/C6 coculture.
Huang Y, Zhai Y, Zhao D, Wu M, Shen Q, Zhao W
BMC Complement Med Ther. 2025; 25(1):75.
PMID: 39994624
PMC: 11849221.
DOI: 10.1186/s12906-025-04751-y.
Unveiling the molecular mechanisms of Danggui-Shaoyao-San against Alzheimer's disease in APP/PS1 mice via integrating proteomic and metabolomic approaches.
Wu Q, Wang W, Huang Z, Lin X, Yao M, Cai C
Alzheimers Res Ther. 2024; 16(1):251.
PMID: 39563386
PMC: 11577849.
DOI: 10.1186/s13195-024-01618-1.
Danggui Shaoyao San and disassembled prescription: neuroprotective effects via AMPK/mTOR-mediated autophagy in mice.
Cheng X, Dai Y, Shang B, Zhang S, Lin L, Wu Q
BMC Complement Med Ther. 2024; 24(1):298.
PMID: 39127649
PMC: 11317013.
DOI: 10.1186/s12906-024-04588-x.
Danggui-Shaoyao-San protects against non-alcoholic steatohepatitis via modulation of hepatic APP protein, Lysosomal CTSB release, and NF-κB activation.
Gao S, An Z, Zhang Q, Sun Q, Huang Q, Shi L
Heliyon. 2024; 10(14):e34213.
PMID: 39114010
PMC: 11305236.
DOI: 10.1016/j.heliyon.2024.e34213.
The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects.
Liu L, Liang J, Liu Y, Liu B, Dong X, Cai W
Heliyon. 2024; 10(9):e30523.
PMID: 38726205
PMC: 11079309.
DOI: 10.1016/j.heliyon.2024.e30523.
Intestinal flora study reveals the mechanism of Danggui Shaoyao San and its decomposed recipes to improve cognitive dysfunction in the rat model of Alzheimer's disease.
Jin Y, Liang S, Qiu J, Jin J, Zhou Y, Huang Y
Front Cell Infect Microbiol. 2023; 13:1323674.
PMID: 38076462
PMC: 10699443.
DOI: 10.3389/fcimb.2023.1323674.
Network pharmacology implicates traditional Chinese medicine in regulating systemic homeostasis to benefit Alzheimer's disease.
Tsai S, Huang H
Tzu Chi Med J. 2023; 35(2):120-130.
PMID: 37261294
PMC: 10227678.
DOI: 10.4103/tcmj.tcmj_125_22.
Literature review on the interdisciplinary biomarkers of multi-target and multi-time herbal medicine therapy to modulate peripheral systems in cognitive impairment.
Park S, Lee S, Zhao H, Kim J, Jang J, Choi Y
Front Neurosci. 2023; 17:1108371.
PMID: 36875644
PMC: 9978226.
DOI: 10.3389/fnins.2023.1108371.
Research progress in traditional Chinese medicine in the treatment of Alzheimer's disease and related dementias.
Tan W, Qi L, Hu X, Tan Z
Front Pharmacol. 2022; 13:921794.
PMID: 36506569
PMC: 9729772.
DOI: 10.3389/fphar.2022.921794.
Yuan-Zhi decoction in the treatment of Alzheimer's disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation.
Wu Q, Li X, Jiang X, Yao D, Zhou L, Xu Z
Front Pharmacol. 2022; 13:893244.
PMID: 36091836
PMC: 9451491.
DOI: 10.3389/fphar.2022.893244.
Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease.
Yang J, Li C, Liu Y, Han Y, Zhao H, Luo S
Front Pharmacol. 2022; 13:832299.
PMID: 36059953
PMC: 9437281.
DOI: 10.3389/fphar.2022.832299.
A Review of Traditional Chinese Medicine, Buyang Huanwu Decoction for the Treatment of Cerebral Small Vessel Disease.
Sun L, Ye X, Wang L, Yu J, Wu Y, Wang M
Front Neurosci. 2022; 16:942188.
PMID: 35844225
PMC: 9278698.
DOI: 10.3389/fnins.2022.942188.
Medicine-Food Herbs against Alzheimer's Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action.
Guo P, Zhang B, Zhao J, Wang C, Wang Z, Liu A
Molecules. 2022; 27(3).
PMID: 35164167
PMC: 8839204.
DOI: 10.3390/molecules27030901.
Neuroprotective Effect of Danggui Shaoyao San via the Mitophagy-Apoptosis Pathway in a Rat Model of Alzheimer's Disease.
Song Z, Luo D, Wang Y, Zheng Y, Chen P, Xia X
Evid Based Complement Alternat Med. 2021; 2021:3995958.
PMID: 34621321
PMC: 8492282.
DOI: 10.1155/2021/3995958.
Effects of Co-Administration of Icariin and Saponins on Intestinal Microbiota and Hippocampal Protein Expression in a Mouse Model of Alzheimer's Disease.
Zhang T, Dong K, Xiao L, Li G, Zhang Z
Neuropsychiatr Dis Treat. 2020; 16:2169-2179.
PMID: 33061388
PMC: 7519864.
DOI: 10.2147/NDT.S253972.
Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease.
Wu Q, Chen Y, Gu Y, Fang S, Li W, Wang Q
BMC Complement Med Ther. 2020; 20(1):282.
PMID: 32948180
PMC: 7501700.
DOI: 10.1186/s12906-020-03066-4.